Pascal-Raphael Blersch from Universitätsklinikum Erlangen investigate the efficacy of combining hyperthermic treatments with chemotherapeutics, such as cisplatin, docetaxel, & mitoxantrone, to develop better therapies for specific melanoma subtypes.
doi.org/10.1167/iovs.66.12.71